Galecto - Rasio total nilai perusahaan marang pendapatan GLTO

Logo perusahaan publik galecto.com (GLTO)

Galecto, Inc. (GLTO) is creating a niche monopoly in cancer and fibrosis therapy, which will ensure pricing power, although the company is currently merely surviving on its remaining cash. The EV/Sales ratio helps filter speculative noise from the asset's actual strength, while 0.00 reflects the current level of this metric. Prospects depend on the effectiveness of combating tissue scarring and the availability of funds for testing.

GLTO Galecto, Inc.: Rasio nilai perusahaan marang pendapatan ing interval 23.11.2025 - 10.03.2026

Galecto Inc - rincian analitis lan metrik utama (GLTO)

- rega saham lan prakiraan rega para ahli:
Analisis wiwitan perusahaan:Galecto, Inc. - GLTO
Produk mawa merek Galecto

Galecto, Inc. (GLTO) ability to fund clinical trials for galectin-3 inhibitors determines the business's market value, which this metric compares against current sales, excluding the impact of debt load. An analysis of the Enterprise Value to Sales ratio allows an investor to identify growth or stagnation phases, determining the fundamental undervaluation of the asset during periods of market lull to minimize risks while preserving capital.

Analisis pesaing Galecto, Inc.

ASND: Rasio nilai perusahaan marang pendapatan|MDGL: Multiplikator EV/Sales|CORT - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Rhythm Corp|Akero Corp (AKRO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan metsera.com (MTSR)|Nilai perusahaan marang pendapatan moonlaketx.com MLTX|Multiplikator EV/Sales CRNX (Crinetics Pharmaceuticals, Inc.)|NAMS: Rasio nilai perusahaan marang pendapatan|SLNO - Rasio nilai perusahaan marang pendapatan|Amicus Pharma (FOLD) - Nilai perusahaan marang pendapatan|ETNB: Multiplikator EV/Sales|AGIO - Rasio total nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan GPCR|Multiplikator nilai perusahaan marang pendapatan MiMedx MDXG|Rasio nilai perusahaan marang pendapatan Rezolute Corp (RZLT)|Nilai perusahaan marang pendapatan Lexicon Corp LXRX|Rasio nilai perusahaan marang pendapatan MBX Biosciences, Inc. MBX|Multiplikator EV/Sales altimmune.com ALT|AARD - Rasio nilai perusahaan marang pendapatan|Sagimet - Koefisien nilai perusahaan marang pendapatan|BioAge Labs Inc. (BIOA) - Rasio nilai perusahaan marang pendapatan|Nilai perusahaan marang volume dodolan BMEA (Biomea Fusion, Inc.)|QNCX (quincetx.com) - Multiplikator EV/Sales|GUTS: Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan vtvtherapeutics.com (VTVT)|ATPC (Agape ATP) - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Pluristem Therapeutics PLUR|SYBX: Rasio nilai perusahaan marang pendapatan|lipocine.com - Multiplikator EV/Sales|Nilai perusahaan marang volume dodolan MTNB|SPRB: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Carmell Corp. (CTCX)|LUMO (Lumos Therapeutics) - Multiplikator EV/Sales|Organovo Corp (ONVO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Radius Recycling (RDUS)